AZ’s Imfinzi is the first NHS immunotherapy for a form of stomach cancer, while MSD’s Winrevair gets a green light for rare respiratory disease PAH.

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844